Coronavirus Global Updates, Feb 10 :::: India Logs 11, 067 New COVID-19 Cases In Last 24 Hours

Bulls n Bears bulls at bullszimbabwe.com
Wed Feb 10 12:15:16 CAT 2021


	
 


 <https://bullszimbabwe.com/> 

 


 

 <http://www.bullszimbabwe.com> Bullszimbabwe.com
<mailto:info at bulls.co.zw?subject=View%20and%20Comments> Views & Comments
<https://bullszimbabwe.com/category/blogs/bullish-thoughts/> Bullish
Thoughts        <http://www.twitter.com/BullsBears2010> Twitter
<https://www.facebook.com/BullsBearsZimbabwe> Facebook
<http://www.linkedin.com/pub/bulls-n-bears-zimbabwe/57/577/72> LinkedIn
<https://chat.whatsapp.com/CF6wllAfScU9Wr6dXxoQnO> WhatsApp
<mailto:info at bulls.co.zw?subject=Unsubscribe> Unsubscribe

 


 

 


Coronavirus Global Updates, Feb 10 :::: India Logs 11,067 New COVID-19 Cases
In Last 24 Hours

 


 

 


 <https://www.nicozdiamond.co.zw/> 

 


 

 



Zimbabwe COVID19 Update


COVID-19 update: As at 09 February 2021, Zimbabwe had 34 781 confirmed
cases, including 29 289 recoveries and 1 353 deaths.





 


India Logs 11,067 New COVID-19 Cases In Last 24 Hours


The new cases take the cumulative count of people infected with the virus in
the country to 1,08,58,371, including 1,41,511 active cases and 1,05,61,608
recoveries.


New Delhi: 

India has reported 11,067 new COVID-19 cases and 13,087 recoveries in the
last 24 hours, informed the Union Ministry of Health and Family Welfare on
Wednesday.

The new cases take the cumulative count of people infected with the virus in
the country to 1,08,58,371, including 1,41,511 active cases and 1,05,61,608
recoveries.

With 94 deaths registered in the last 24 hours, the total number of deaths
toll now stands at 1,55,252.

As many as 66,11,561 COVID-19 vaccinations have been administered to the
people in the country so far, the Ministry said.

A total of 20,33,24,655 samples have been tested for the coronavirus, out of
which 7,36,903 samples were tested on Tuesday, the Indian Council of Medical
Research (ICMR) informed.




U.S. Vaccine Hesitancy Cited; Lab Origin Rejected: Virus Update
Only about half of U.S. adults surveyed late last year said they were
certain or very likely to get a Covid-19 vaccine, according to a new report
from by the Centers for Disease Control and Prevention.


A World Health Organization investigation in China found that the
coronavirus most likely jumped to humans through an animal or frozen
wildlife products, and a theory that it resulted from a laboratory leak is
"extremely unlikely."

Israel said almost all of its virus patients who died in the past 30 days
weren't vaccinated. The U.K. outlined plans for
<https://www.bloomberg.com/news/articles/2021-02-09/u-k-threatens-10-years-j
ail-for-covid-quarantine-rule-breakers> restrictions designed to prevent new
strains entering the country. Ireland reported the fewest new cases since
Dec. 19, even as the government plotted more travel restrictions to hold off
new variants.

 


Astra Vaccine Urged for South Africa 
The lead researcher of the South African trial of AstraZeneca Plc's
coronavirus vaccine urged authorities in the country to continue using the
shot to cut death and hospitalization rates and the chance of further virus
mutations.


Early data of a small phase trial showed that AstraZeneca's vaccine has
limited efficacy against mild disease caused by the B.1.351 variant that's
now dominant in South Africa, prompting the government to suspend plans to
give it to health workers. The study didn't determine whether it protects
against severe Covid-19 cases and deaths because most participants were
"young healthy adults," according to the company.


U.S. Vaccine Hesitancy Cited in CDC Report 
Only about half of U.S. adults surveyed late last year said they were
certain or very likely to get a Covid-19 vaccine, according to a new report
from by the Centers for Disease Control and Prevention.


The study, released Tuesday in the CDC's Morbidity and Mortality Weekly
Report, surveyed 3,541 people in September and 2,033 individuals in
December. The first Covid-19 vaccine, developed by Pfizer Inc. and BioNTech
SE was authorized by the Food and Drug Administration on Dec. 11. A similar
vaccine made by Moderna Inc. was cleared for emergency-use shortly
thereafter.

A greater proportion of people indicated that they planned to get a vaccine
in December than in September. But the finding showed that more work needed
to be done to address concerns about the vaccines after they were cleared
for use, said agency researchers who co-wrote the report.


Pfizer Plant in Belgium Resumes Production 
Pfizer Inc. said it has resumed manufacturing the Covid-19 vaccine it
developed in partnership with BioNTech SE at its plant in Belgium after
temporarily reducing production to upgrade the facility's production lines,
the Wall Street Journal reported.


A Pfizer spokeswoman said Tuesday the changes in Puurs, Belgium, have
finished, and during the week of Jan. 25 the company resumed its original
delivery schedule of doses to the European Union, the Journal said. Pfizer
also plans to increase deliveries next week to meet its contractual
obligations for the first quarter, the spokeswoman said.


Irish Outbreak Continues to Ease 
Ireland reported the fewest new coronavirus cases since Dec. 19, even as the
government plots more travel restrictions to hold off new variants arriving
in the country. There were 556 newly confirmed cases, the health ministry
said, with 68 deaths. Ireland's government plans tighter restrictions on
passengers arriving from South Africa and Brazil, while it will make it
mandatory for some people quarantine in designated hotels when they arrive
in the country.




U.K. Advisers Raise Concerns on New Variants 
A U.K. government advisory panel raised concerns over a further mutation of
the so-called Kent variant, while reassuring the public that vaccines should
still provide protection.


The New and Emerging Respiratory Virus Threats Advisory Group said the
additional E484K mutation of the B.1.1.7 Kent virus strain has been
designated a "variant of concern", according to a government statement. The
mutation was first identified in Bristol, England.

The mutation has also been found on another original strain of the virus --
known as A.23.1 -- which the panel has now classified as a "variant under
investigation."

The E48K mutation has been seen in a number of variants, including those
from South Africa and Brazil. Public Health England has found 76 cases of
the two new variants, the government said.


Greece Imposes Stricter Lockdown 
The Greek government has reintroduced a stricter lockdown in Athens and the
surrounding Attica region in a bid to curb a recent spike in new coronavirus
cases and hospitalizations. The area accounts for around half of Greece's
population of almost 11 million.


Cuomo Says U.S. to Boost Doses by Another 5% 
The U.S. government plans to increase vaccine allocations by another 5% for
the next three weeks, New York Governor Andrew Cuomo said.


The additional 5%, announced on a White House call with governors Tuesday,
follows an initial 20% increase and then a subsequent 5%. Cuomo, during a
call afterward with reporters, said he doesn't expect a major supply boost
until Johnson & Johnson's single-dose vaccine is produced.


Dutch Parliament Extending Curfew 
A majority in the lower house of Dutch parliament agreed with a government
proposal to extend a nighttime curfew until early March.


The measure, which triggered riots when first introduced at the end of
January, is added to the country's lockdown that was already prolonged.
Despite decreasing overall infection numbers on a weekly basis since the end
of last year, Prime Minister Mark Rutte last week warned of "an inevitable
third wave" after the Dutch health agency estimated that a more contagious
virus strain first discovered in the U.K. accounted for about two-thirds of
all new infections in the week ending Feb. 2.

 

 

 


 


 


 

 

 

 


 

INVESTORS DIARY 2021

 


Company

Event

Venue

Date & Time

 


 

 

 

 

 


 

 

 

 

 


Companies under Cautionary

 

 

 


 

 

 

 


ART

PPC

Dairibord

 


Starafrica

Fidelity

Turnall

 


Medtech

Zimre

Nampak Zimbabwe

 


 

 


DISCLAIMER: This report has been prepared by Bulls 'n Bears, a division of
Faith Capital (Pvt) Ltd for general information purposes only and does not
constitute an offer to sell or the solicitation of an offer to buy or
subscribe for any securities. The information contained in this report has
been compiled from sources believed to be reliable, but no representation or
warranty is made or guarantee given as to its accuracy or completeness. All
opinions expressed and recommendations made are subject to change without
notice. Securities or financial instruments mentioned herein may not be
suitable for all investors. Securities of emerging and mid-size growth
companies typically involve a higher degree of risk and more volatility than
the securities of more established companies. Neither Faith Capital nor any
other member of Bulls 'n Bears nor any other person, accepts any liability
whatsoever for any loss howsoever arising from any use of this report or its
contents or otherwise arising in connection therewith. Recipients of this
report shall be solely responsible for making their own independent
investigation into the business, financial condition and future prospects of
any companies referred to in this report. Other  Indices quoted herein are
for guideline purposes only and sourced from third parties.

 


 

 


(c) 2021 Web: <http://www.bullszimbabwe.com>  www.bullszimbabwe.com Email:
<mailto:info at bulls.co.zw> info at bulls.co.zw Tel: +263 4 2927658 Cell: +263 77
344 1674

 


 

 

 

 

 

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210210/cf16171e/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 9458 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210210/cf16171e/attachment-0001.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image003.jpg
Type: image/jpeg
Size: 802315 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210210/cf16171e/attachment-0002.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image004.jpg
Type: image/jpeg
Size: 95470 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210210/cf16171e/attachment-0003.jpg>


More information about the Bulls mailing list